KANE BIOTECH
Kane Biotech Inc., a biotechnology company, engages in the research and development of products to prevent and disperse biofilms in medical and industrial applications. Its products include ALEDEX, an antimicrobial/antibiofilm composition comprising protamine sulfate and chlorhexidine, with applications in anti-infective medical device coatings, animal care and dairy, and food processing industries; DispersinB, an antibiofilm enzyme that inhibits, as well as disperses microbial biofilms, with applications in wound care, medical devices, oral care, and animal healthcare; and a toothpaste and mouthwash additive based on competence stimulating peptide technology for preventing and dispersing dental plaque biofilms. The company was founded in 2001 and is headquartered in Winnipeg, Canada.
KANE BIOTECH
Industry:
Biotechnology Health Care Medical
Founded:
2001-01-01
Address:
Winnipeg, Manitoba, Canada
Country:
Canada
Website Url:
http://www.kanebiotech.com
Total Employee:
1+
Status:
Active
Contact:
2044531314
Email Addresses:
[email protected]
Total Funding:
22.88 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome
Similar Organizations
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Pivot Financial Inc
Pivot Financial Inc investment in Post-IPO Debt - Kane Biotech
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Kane Biotech
Government of Canada
Government of Canada investment in Grant - Kane Biotech
National Research Council of Canada Industrial Research Assistance Program
National Research Council of Canada Industrial Research Assistance Program investment in Grant - Kane Biotech
Government of Canada
Government of Canada investment in Grant - Kane Biotech
Western Economic Diversification Canada
Western Economic Diversification Canada investment in Post-IPO Debt - Kane Biotech
Manitoba
Manitoba investment in Grant - Kane Biotech
National Research Council of Canada Industrial Research Assistance Program
National Research Council of Canada Industrial Research Assistance Program investment in Grant - Kane Biotech
Genesys Venture
Genesys Venture investment in Pre Seed Round - Kane Biotech
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-05 | Kane Biotech Appoints Dr. Gregory Schultz as Chief Scientific Officer |
Official Site Inspections
http://www.kanebiotech.com
- Host name: cloudproxy10018.sucuri.net
- IP address: 192.124.249.18
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Kane Biotech"
About Us - Kane Biotech
Kane Biotech
Creating smarter ways to fight bacteria Leading the advancement of technologies and products that break up biofilms and destroy bacteria. For over 20 years Kane Biotech’s R+D division has been developing new technologies and …See details»
Profile :: Kane Biotech Inc. (KNE)
[email protected]. Industry Classifications. Sector: Healthcare. Industry: Biotechnology. NAICS: Biological Product (Except Diagnostic) Manufacturing (325414) SIC: Pharmaceutical and Medicine Industry (3741) Kane Biotech. …See details»
Kane Biotech Inc. (KNE)
Dec 3, 2024 [email protected]. Investor Relations. Kane Biotech Inc. Nicole Sendey Investor Relations & Public Relations T: 204-453-1301 [email protected]. Transfer Agent. Canadian Stock Transfer …See details»
Kane Biotech Inc. - LinkedIn
With 81 patents and patents pending, Kane Biotech is Kane Biotech is THE Biofilm Company. Creating smarter ways to fight bacteria, Kane is leading the advancement of technologies and …See details»
Kane Biotech - Crunchbase Company Profile & Funding
Organization. Kane Biotech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email [email protected]; Phone …See details»
Kane Biotech Strengthens Board with Biotech Executive
Kane Biotech. 290-100 Innovation Drive Winnipeg, Manitoba, Canada, R3T 6G2 (204) 453-1301 | [email protected]See details»
Kane Biotech - Company Profile - Tracxn
Nov 13, 2024 Kane Biotech - Developer of therapeutic solutions to prevent and remove biofilms. Public Company. Raised funding over 7 rounds from 4 investors. Kane Biotech has 147 …See details»
Kane Biotech - Overview, News & Similar companies - ZoomInfo
Apr 14, 2024 View Kane Biotech (www.kanebiotech.com) location in Manitoba, Canada , revenue, industry and description. Find related and similar companies as well as employees …See details»
Kane Biotech - Craft
Jul 12, 2024 Kane Biotech is a biotechnology company engaged in the research, development, and commercialization of technologies dispersing biofilms. It discovers and commercializes …See details»
Biofilms - Kane Biotech
It was not until the 1990s that the elaborate organization of attached bacteria was identified as a biofilm xviii. Research on biofilms has only progressed rapidly in the last decade, leading to a …See details»
Kane Biotech Receives Bioscience Association Manitoba Company …
WINNIPEG, Manitoba, March 08, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that at the …See details»
Kane Biotech Receives Bioscience Association Manitoba
WINNIPEG, Manitoba, March 08, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that at the …See details»
Kane Biotech Announces Third Quarter 2024 Financial Results
Nov 28, 2024 A webcast of the call will be available on the Company's website at kanebiotech.com under "News/Events" in the Investors section of the Kane Biotech website at …See details»
Raising Kane: The Secret to How Kane Biotech Got Its Name
Jun 22, 2023 Kane Biotech. 290-100 Innovation Drive Winnipeg, Manitoba, Canada, R3T 6G2 (204) 453-1301 | [email protected]See details»
Kane Biotech Receives ISO 13485:2016 MDSAP Quality Certification
Jul 17, 2024 Provides access to Canadian, Australian, New Zealand and Brazilian markets. WINNIPEG, Manitoba, July 17, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; …See details»
Kane Biotech Announces Change in US Distribution Partner for
Nov 27, 2024 Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or …See details»
Our Facilities | Kane Biotech
Kane Biotech. 290-100 Innovation Drive Winnipeg, Manitoba, Canada, R3T 6G2 (204) 453-1301 | [email protected]See details»
Kane Biotech Signs Worldwide License Agreement with Montreal …
Jun 25, 2024 First Commercial Agreement for DispersinB® WINNIPEG, Manitoba, June 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane …See details»
Kane Biotech Announces $3,000,000 Private Placement Offering
Dec 3, 2024 --Kane Biotech Inc. announces today that it intends to undertake a non-brokered private placement offering of up to 30,000,000 common shares of the Company at a price of …See details»